PTC Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
PTCT
CUSIP
69366J200
Type
Equity
Class
COM
Num filers
209
Total reported value, excl. options
$3.30B
Manager Report Date Value ($000) Shares Option Type